Biovac Greenfield Vaccine Manufacturing Facility Expansion (Project Kili)
Summary · 1 min read
Biovac is expanding its Cape Town operations by constructing a new vaccine manufacturing plant on adjacent land acquired from the City of Cape Town. Backed by IFC loans totaling $110 million alongside other funding, the facility will produce critical vaccines (such as Cholera, Polio, Rotavirus, PCV) for sub-Saharan Africa. Construction is scheduled to begin in 2026, with commercial operations starting in 2029.
- Closing
- 25 Mar 20312026 - 2029 (Construction to Operational Phase) contract
- Location
- Cape Town, Western Cape
- Published
- 23 Aug 2026
Do you qualify? 3 requirements found
-
Compliance with IFC Environmental & Social Performance StandardsMandatory
-
Acquisition of land development rights from the City of Cape TownMandatory
-
Adherence to international pharmaceutical and biological manufacturing standardsMandatory
Documents you must submit
- Environmental and Social Review Summary (ESRS)
- Environmental and Social Action Plan (ESAP)
- Facility Architectural and Engineering Designs
Evaluation criteria
Compliance with IFC Environmental and Social Performance Standards, WHO GMP qualification, financial feasibility, and technical capabilities in pharmaceutical infrastructure.
Tender documents
Also available: submission address & procurement contact-
Original noticeExternal linkSign up to open
Free to sign up · Already have an account? Sign in
Similar tenders closing soon
All Medical and Scientific Supplies tenders →-
1 day left
Supply and Delivery of Clinic Medicine
City of uMhlathuze · KwaZulu-Natal -
1 day left
Supply, Installation, and Maintenance of Ophthalmic Equipment for 2 Military Hospital
Department of Defence · Western Cape -
1 day left
Supply and Delivery of Laboratory Consumables for NHLS Sandringham Campus
National Health Laboratory Service · Gauteng